Solid Tumours

Solid Tumours
2025-04-04T00:00:00.000+11:00
Ongoing

Ideate-Pantumor02

Ideate-Pantumor02
Basket - Other

A phase 2 pan tumour, open label study to evaluate the efficacy and safety of Ifinatamab Deruxtecan (I-DXD) in subjects with recurrent or metastatic solid tumours.

A phase 2 pan tumour, open label study to evaluate the efficacy and safety of Ifinatamab Deruxtecan (I-DXD) in subjects with recurrent or metastatic solid tumours.

Trial overview

Clinical Area

Medical Oncology

Disease

Basket - Metastic

Disease site

Basket

Study Phase

II

Trial Identifiers

Registration number: NCT06330064

https://clinicaltrials.gov/

GenesisCare Location(s)
North Shore
location pin icon

North Shore Health Hub, Tower A, Level 1, 7 Westbourne St, St Leonards, NSW, 2065, Australia

phone icon (02) 8037 4100 email icon admin.northshore@genesiscare.com
NSW
North Shore
Principal Investigator(s)
Medical Oncologist

Dr Adrian Lee

BSc (Med) MBBS (Hons) FRACP PhD

Dr Adrian Lee
location pin icon

North Shore

View Profile
Profile Image - Dr Adrian Lee

Clinical trials enquiries

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.